These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 6707942
1. Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution. Allen TM, Murray L, MacKeigan S, Shah M. J Pharmacol Exp Ther; 1984 Apr; 229(1):267-75. PubMed ID: 6707942 [Abstract] [Full Text] [Related]
3. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. Allen TM, Everest JM. J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864 [Abstract] [Full Text] [Related]
6. Liver pathology accompanying chronic liposome administration in mouse. Allen TM, Smuckler EA. Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):281-90. PubMed ID: 2417296 [Abstract] [Full Text] [Related]
7. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Gabizon A, Goren D, Fuks Z, Barenholz Y, Dagan A, Meshorer A. Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331 [Abstract] [Full Text] [Related]
8. Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomes. Allen TM, Murray L, Alving CR, Moe J. Can J Physiol Pharmacol; 1987 Feb; 65(2):185-90. PubMed ID: 2436731 [Abstract] [Full Text] [Related]
9. Effects of liposome dose and the presence of lymphosarcoma cells on blood clearance and tissue distribution of large unilamellar liposomes in mice. Ellens H, Morselt HW, Dontje BH, Kalicharan D, Hulstaert CE, Scherphof GL. Cancer Res; 1983 Jun; 43(6):2927-34. PubMed ID: 6687832 [Abstract] [Full Text] [Related]
10. Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation. Beaumier PL, Hwang KJ, Slattery JT. Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):277-89. PubMed ID: 6844745 [Abstract] [Full Text] [Related]
11. Effect of long-term Intralipid administration in mice. Allen TM, Murray L. Can J Physiol Pharmacol; 1986 Jul; 64(7):1006-10. PubMed ID: 3768791 [Abstract] [Full Text] [Related]
12. Modulation of reticuloendothelial activity with liposomes. Hojo H, Hoshino Y, Kurita T, Hashimoto Y. Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):373-85. PubMed ID: 3992015 [Abstract] [Full Text] [Related]
13. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S. Clin Cancer Res; 2003 Dec 15; 9(17):6551-9. PubMed ID: 14695160 [Abstract] [Full Text] [Related]
14. alpha-Glucosidase-albumin conjugates: effect of chronic administration in mice. Allen TM, Murray L, Bhardwaj D, Poznansky MJ. J Pharmacol Exp Ther; 1985 Jul 15; 234(1):250-4. PubMed ID: 3891969 [Abstract] [Full Text] [Related]
15. Liposome disposition in vivo: effects of pre-dosing with lipsomes. Abra RM, Bosworth ME, Hunt CA. Res Commun Chem Pathol Pharmacol; 1980 Aug 15; 29(2):349-60. PubMed ID: 7414053 [Abstract] [Full Text] [Related]
16. Studies on the tissue distribution of liposome-associated clofazimine, an antileprosy drug. Sritharan M. Methods Find Exp Clin Pharmacol; 1993 Mar 15; 15(2):107-11. PubMed ID: 8487593 [Abstract] [Full Text] [Related]
18. Measurement of carbon clearance in mice as toxicity parameter for liposomal preparations. Fichtner I, Kniest A, Arndt D. In Vivo; 1992 Mar 15; 6(1):113-7. PubMed ID: 1627737 [Abstract] [Full Text] [Related]
19. Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes. Longman SA, Tardi PG, Parr MJ, Choi L, Cullis PR, Bally MB. J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1177-84. PubMed ID: 8531079 [Abstract] [Full Text] [Related]